User profiles for Alysson Henrique Urbanski
 | Alysson Henrique UrbanskiDoutorando, Universidade de São Paulo Verified email at usp.br Cited by 119 |
[HTML][HTML] Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape
…, JY Magawa, IP Daher, AH Urbanski… - Frontiers in …, 2023 - frontiersin.org
Introduction Considering the likely need for the development of novel effective vaccines
adapted to emerging relevant CoV-2 variants, the increasing knowledge of epitope recognition …
adapted to emerging relevant CoV-2 variants, the increasing knowledge of epitope recognition …
Large-scale assessment of human mobility during COVID-19 outbreak
L Queiroz, JL Melo, G Barboza, AH Urbanski, A Nicolau… - 2020 - osf.io
Social distancing is an important measure to prevent the collapse of public health systems
during the COVID-19 pandemic. While some countries have managed to impose a strong …
during the COVID-19 pandemic. While some countries have managed to impose a strong …
Investigação de marcadores moleculares sanguíneos durante a infecção pelo vírus Chikungunya
AH Urbanski - 2023 - teses.usp.br
A febre Chikungunya (CHIKF) é uma infecção viral causada pelo vírus Chikungunya (CHIKV).
Os sintomas agudos incluem febre alta de início súbito, erupção cutânea, poliartrite e …
Os sintomas agudos incluem febre alta de início súbito, erupção cutânea, poliartrite e …
[HTML][HTML] Immunodominant B cell epitope in a hotspot mutation site and mechanism of immune escape for SARS-CoV-2
…, HA Arcuri, JY Magawa, IP Daher, AH Urbanski… - 2021 - europepmc.org
Recent SARS-CoV-2 variants pose important concerns due to their higher transmissibility (1)
and escape (2) from previous infections or vaccine-induced neutralizing antibodies (nAb). …
and escape (2) from previous infections or vaccine-induced neutralizing antibodies (nAb). …
Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B. 1.351 and P. 1 mutation hotspot: implications for viral spread and antibody escape
…, HA Arcuri, JY Magawa, IP Daher, AH Urbanski… - medRxiv, 2021 - medrxiv.org
Recent SARS-CoV-2 variants pose important concerns due to their higher transmissibility (
1 ) and escape ( 2 ) from previous infections or vaccine-induced neutralizing antibodies (nAb)…
1 ) and escape ( 2 ) from previous infections or vaccine-induced neutralizing antibodies (nAb)…
[CITATION][C] Fosfolipaes-D no loxoscelismo: mecanismos moleculares induzidos pela interação de toxinas do veneno de aranhas-marrons com a superfície de células …
Identificação em larga escala de genes que medeiam a quiescência celular ea diferenciação para lactogênese induzidas pela laminina
MCS Botelho - 2022 - teses.usp.br
… Imoto Nakaya do Departamento de Farmácia da Faculdade de Ciências Farmacêuticas da
USP, onde trabalhamos diretamente com o aluno de doutorado Alysson Henrique Urbanski. …
USP, onde trabalhamos diretamente com o aluno de doutorado Alysson Henrique Urbanski. …
[PDF][PDF] Memorial Descritivo
L ONO - 2015 - cppd.ufpr.br
… Pedro Henrique Oliveira de Salves, Curso de Farmácia, PID: Disciplina de Microbiologia
aplicada … Alysson Henrique Urbanski, Curso de Biomedicina, Estágio supervisionado curricular …
aplicada … Alysson Henrique Urbanski, Curso de Biomedicina, Estágio supervisionado curricular …
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Y Wu, F Wang, C Shen, W Peng, D Li, C Zhao, Z Li, S Li… - Science, 2020 - science.org
Neutralizing antibodies could potentially be used as antivirals against the coronavirus disease
2019 (COVID-19) pandemic. Here, we report isolation of four human-origin monoclonal …
2019 (COVID-19) pandemic. Here, we report isolation of four human-origin monoclonal …
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Neutralizing antibodies have become an important tool in treating infectious diseases.
Recently, two separate approaches yielded successful antibody treatments for Ebola—one from …
Recently, two separate approaches yielded successful antibody treatments for Ebola—one from …
